Detalhe da pesquisa
1.
Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failure.
World J Urol
; 41(11): 3195-3203, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-36811732
2.
BCG-unresponsive high-grade non-muscle invasive bladder cancer: what does the practicing urologist need to know?
World J Urol
; 39(11): 4037-4046, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-33772322
3.
Surgical complications risk in obese and overweight recipients for kidney transplantation: a predictive morphometric model based on sarcopenia and vessel-to-skin distance.
World J Urol
; 39(6): 2223-2230, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32785765
4.
Efficacy of HIVEC in patients with high-risk non-muscle invasive bladder cancer who are contraindicated to BCG and in patients who fail BCG therapy.
Int J Hyperthermia
; 38(1): 1633-1638, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34775896
5.
Clinical interest of PD-L1 immuno-histochemistry expression as a predictive factor of Bacillus Calmette Guerin (BCG) efficacy in refractory high-risk non-muscle-invasive bladder cancer (NMIBC).
World J Urol
; 38(6): 1517-1524, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-31486884
6.
Temporary contraindication of obese recipients in kidney transplantation: A new morphometric tool for decision support.
Clin Transplant
; 34(4): e13829, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32065442
7.
Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art.
World J Urol
; 37(1): 115-123, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-29858701
8.
Final results of the phase III URO-BCG 4 multicenter study: efficacy and tolerance of one-third dose BCG maintenance in nonmuscle invasive bladder cancer.
Anticancer Drugs
; 28(3): 335-340, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27902496
9.
Observational Studies Requested by European Health Authorities: Governmental Interference or an Enhancement of Everyday Urological Practice? The Hexvix® Observational Patients Evaluation Study as an Example of What to Expect.
Urol Int
; 99(3): 358-366, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28787725
10.
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin.
BJU Int
; 118(1): 44-52, 2016 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-26469362
11.
Urology surgical activity and COVID-19: risk assessment at the epidemic peak: a Parisian multicentre experience.
BJU Int
; 126(4): 436-440, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32640121
12.
Efficacy and tolerance of one-third full dose bacillus Calmette-Guérin maintenance therapy every 3 months or 6 months: two-year results of URO-BCG-4 multicenter study.
Int J Urol
; 22(1): 53-60, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25256813
13.
[Metastatic lymph node collision of a prostatic adenocarcinoma and an urothelial carcinoma and review of the literature]. / Double métastase ganglionnaire d'un adénocarcinome prostatique et d'un carcinome urothélial et revue de la littérature.
Ann Pathol
; 35(6): 496-501, 2015 Dec.
Artigo
Francês
| MEDLINE | ID: mdl-26597142
14.
ERG expression in prostate cancer: the prognostic paradox.
Prostate
; 74(15): 1481-7, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25175352
15.
Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?
BJU Int
; 114(4): 476-83, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-24433259
16.
Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer?
BJU Int
; 113(2): 189-99, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24112742
17.
Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomy.
World J Urol
; 32(2): 507-12, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23812497
18.
[Non-muscle invasive bladder cancer]. / Tumeurs de la vessie n'infiltrant pas le muscle.
Rev Prat
; 64(10): 1382-5, 2014 Dec.
Artigo
Francês
| MEDLINE | ID: mdl-25665317
19.
Is an extended 20-core prostate biopsy protocol more efficient than the standard 12-core? A randomized multicenter trial.
J Urol
; 190(1): 77-83, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23313205
20.
Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
J Urol
; 189(6): 2069-76, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23201497